{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:21:00Z","timestamp":1740144060404,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA 2015 CDF - 976"],"award-info":[{"award-number":["TMA 2015 CDF - 976"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2196-9","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T11:21:06Z","timestamp":1506943266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Dziedzom K.","family":"de Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collins S.","family":"Ahorlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Adu-Amankwah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Otchere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedzro K.","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene A.","family":"Larbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George E.","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana-Kwadwo","family":"Biritwum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Boakye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,2]]},"reference":[{"issue":"6","key":"2196_CR1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/QCO.0b013e32833fdee5","volume":"23","author":"MJ Bockarie","year":"2010","unstructured":"Bockarie MJ, Deb RM. Elimination of lymphatic filariasis: do we have the drugs to complete the job? Curr Opin Infect Dis. 2010;23(6):617\u201320.","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"2196_CR2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.trstmh.2003.12.005","volume":"98","author":"PE Simonsen","year":"2004","unstructured":"Simonsen PE, Magesa SM, Dunyo SK, Malecela-Lazaro MN, Michael E. The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania. Trans R Soc Trop Med Hyg. 2004;98(8):462\u201372.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"2196_CR3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4269\/ajtmh.2004.70.63","volume":"70","author":"PE Simonsen","year":"2004","unstructured":"Simonsen PE, Meyrowitsch DW, Mukoko DA, Pedersen EM, Malecela-Lazaro MN, Rwegoshora RT, et al. The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity. Am J Trop Med Hyg. 2004;70(1):63\u201371.","journal-title":"Am J Trop Med Hyg"},{"key":"2196_CR4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-3156.2000.00620.x","volume":"5","author":"EA Ottesen","year":"2000","unstructured":"Ottesen EA. The global programme to eliminate lymphatic filariasis. Trop Med Int Health. 2000;5:591\u20134.","journal-title":"Trop Med Int Health"},{"key":"2196_CR5","volume-title":"Annual Report of the Global Programme to Eliminate Lymphatic Filariasis","author":"World Health Organisation","year":"2002","unstructured":"World Health Organisation. Annual Report of the Global Programme to Eliminate Lymphatic Filariasis. Geneva: WHO; 2002."},{"issue":"1","key":"2196_CR6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-3305-7-46","volume":"7","author":"M Brady","year":"2014","unstructured":"Brady M, GAELF. Seventh meeting of the Global Alliance to Eliminate Lymphatic Filariasis: reaching the vision by scaling up, scaling down, and reaching out. Parasit Vectors. 2014;7(1):46.","journal-title":"Parasit Vectors"},{"issue":"38","key":"2196_CR7","first-page":"489","volume":"90","author":"WHO","year":"2015","unstructured":"WHO. Global programme to eliminate lymphatic filariasis: progress report, 2014. Wkly Epidemiol Rec. 2015;90(38):489\u2013504.","journal-title":"Wkly Epidemiol Rec"},{"issue":"12","key":"2196_CR8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/trstmh\/trx007","volume":"110","author":"N-K Biritwum","year":"2016","unstructured":"Biritwum N-K, Yikpotey P, Marfo BK, Odoom S, Mensah EO, Asiedu O, et al. Persistent \u2018hotspots\u2019 of lymphatic filariasis microfilaraemia despite 14\u00a0years of mass drug administration in Ghana. Trans R Soc Trop Med Hyg. 2016;110(12):690\u20135.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2196_CR9","doi-asserted-by":"publisher","unstructured":"Kanamitie JN, Ahorlu CS, Otchere J, Aboagye -Antwi F, Kwansa - Bentum B, Boakye DA, et al. 12-month longitudinal parasitological assessment of lymphatic filariasis-positive individuals: impact of bi-annual treatment with ivermectin and albendazole. Trop Med Int Health. 2017. doi: 10.1111\/tmi.12974 .","DOI":"10.1111\/tmi.12974"},{"issue":"10","key":"2196_CR10","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1365-3156.2005.01489.x","volume":"10","author":"D Kyelem","year":"2005","unstructured":"Kyelem D, Medlock J, Sanou S, Bonkoungou M, Boatin B, Molyneux DH. Short communication: impact of long-term (14\u00a0years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia. Trop Med Int Health. 2005;10(10):1002\u20134.","journal-title":"Trop Med Int Health"},{"issue":"5","key":"2196_CR11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1473-3099(14)70732-7","volume":"14","author":"M Katabarwa","year":"2014","unstructured":"Katabarwa M, Richards F. Twice-yearly ivermectin for onchocerciasis: the time is now. Lancet Infect Dis. 2014;14(5):373\u20134.","journal-title":"Lancet Infect Dis"},{"key":"2196_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/638429","volume":"2012","author":"N Cruz-Ortiz","year":"2012","unstructured":"Cruz-Ortiz N, Gonzalez RJ, Lindblade KA, Richards FO, Sauerbrey M, Zea-Flores G, et al. Elimination of Onchocerca volvulus transmission in the Huehuetenango focus of Guatemala. J Parasitol Res. 2012;2012:1.","journal-title":"J Parasitol Res"},{"key":"2196_CR13","first-page":"1","volume-title":"Informal consultations on the elimination of onchocerciasis transmission with current tools in Africa\u2014\u2018shrinking the map\u2019. Ouagadougou-Burkina Faso: African Program for Onchocerciasis Control (APOC)","author":"WHO","year":"2009","unstructured":"WHO. Informal consultations on the elimination of onchocerciasis transmission with current tools in Africa\u2014\u2018shrinking the map\u2019. Ouagadougou-Burkina Faso: African Program for Onchocerciasis Control (APOC). 2009. p. 1\u201332."},{"key":"2196_CR14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0035-9203(96)90534-9","volume":"90","author":"DW Meyrowitsch","year":"1996","unstructured":"Meyrowitsch DW, Simonsen PE, Makunde WH. Mass DEC chemotherapy for control of bancroftian filariasis: comparative efficacy of four strategies two years after start of treatment. Trans R Soc Trop Med Hyg. 1996;90:423\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2196_CR15","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMoa021309","volume":"347","author":"MJ Bockarie","year":"2002","unstructured":"Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, et al. Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med. 2002;347:1841\u20138.","journal-title":"N Engl J Med"},{"key":"2196_CR16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pt.2016.09.009","volume":"33","author":"MP Rebollo","year":"2017","unstructured":"Rebollo MP, Bockarie MJ. Can lymphatic filariasis be eliminated by 2020? Trends Parasitol. 2017;33:83\u201392.","journal-title":"Trends Parasitol"},{"issue":"11","key":"2196_CR17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1086\/657063","volume":"51","author":"B Dembele","year":"2010","unstructured":"Dembele B, Coulibaly YI, Dolo H, Konate S, Coulibaly SY, Sanogo D, et al. Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels. Clin Infect Dis. 2010;51(11):1229\u201335.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2196_CR18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/trstmh\/trv027","volume":"109","author":"TT Tafatatha","year":"2015","unstructured":"Tafatatha TT, Ngwira BM, Taegtmeyer M, Phiri AJ, Wilson TP, Banda LG, et al. Randomised controlled clinical trial of increased dose and frequency of albendazole and ivermectin on Wuchereria bancrofti microfilarial clearance in northern Malawi. Trans R Soc Trop Med Hyg. 2015;109(6):393\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2196_CR19","first-page":"1","volume-title":"WHO\/HTM\/NTD\/PCT\/2011","author":"WHO","year":"2011","unstructured":"WHO. Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. In: WHO, editor. WHO\/HTM\/NTD\/PCT\/2011, vol. 4. Geneva: WHO; 2011. p. 1\u201379."},{"issue":"3","key":"2196_CR20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2196_CR21","doi-asserted-by":"crossref","first-page":"e9927","DOI":"10.1371\/journal.pone.0009927","volume":"5","author":"D Souza de","year":"2010","unstructured":"de Souza D, Kelly-Hope L, Lawson B, Wilson M, Boakye D. Environmental factors associated with the distribution of Anopheles gambiae s.s in Ghana; an important vector of lymphatic filariasis and malaria. PLoS One. 2010;5(3):e9927.","journal-title":"PLoS One"},{"issue":"3","key":"2196_CR22","doi-asserted-by":"crossref","first-page":"e0004590","DOI":"10.1371\/journal.pntd.0004590","volume":"10","author":"DK Souza de","year":"2016","unstructured":"de Souza DK, Yirenkyi E, Otchere J, Biritwum N-K, Ameme DK, Sackey S, et al. Assessing lymphatic filariasis data quality in endemic communities in Ghana, using the neglected Tropical Diseases Data Quality Assessment Tool for Preventive Chemotherapy. PLoS Negl Trop Dis. 2016;10(3):e0004590.","journal-title":"PLoS Negl Trop Dis"},{"key":"2196_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1756-3305-5-81","volume":"5","author":"RL Pullan","year":"2012","unstructured":"Pullan RL, Brooker SJ. The global limits and population at risk of soil-transmitted helminth infections in 2010. Parasit Vectors. 2012;5:81.","journal-title":"Parasit Vectors"},{"issue":"1","key":"2196_CR24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4269\/ajtmh.13-0089","volume":"89","author":"GJ Weil","year":"2013","unstructured":"Weil GJ, Curtis KC, Fakoli L, Fischer K, Gankpala L, Lammie PJ, et al. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. Am J Trop Med Hyg. 2013;89(1):11\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"2196_CR25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2307\/3282801","volume":"76","author":"JW Dickerson","year":"1990","unstructured":"Dickerson JW, Eberhard ML, Lammie PJ. A technique for microfilarial detection in preserved blood using nucleopore filters. J Parasitol. 1990;76(6):829\u201333.","journal-title":"J Parasitol"},{"issue":"12","key":"2196_CR26","doi-asserted-by":"crossref","first-page":"e1930","DOI":"10.1371\/journal.pntd.0001930","volume":"6","author":"J Kubofcik","year":"2012","unstructured":"Kubofcik J, Fink DL, Nutman TB. Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection. PLoS Negl Trop Dis. 2012;6(12):e1930.","journal-title":"PLoS Negl Trop Dis"},{"key":"2196_CR27","first-page":"65","volume":"27","author":"DK Souza de","year":"2007","unstructured":"de Souza DK, Offei Owusu I, Otchere J, Adimazoya M, Frempong KK, Ahorlu CS, et al. An evaluation of Wb123 antibody ELISA in individuals treated with ivermectin and albendazole, and implementation challenges in Africa. Pan Afr Med J. 2007;27:65.","journal-title":"Pan Afr Med J"},{"issue":"4","key":"2196_CR28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.2008.79.480","volume":"79","author":"D Kyelem","year":"2008","unstructured":"Kyelem D, Biswas G, Bockarie MJ, Bradley MH, El-Setouhy M, Fischer PU, et al. Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. Am J Trop Med Hyg. 2008;79(4):480\u20134.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"2196_CR29","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-3156.2004.01247.x","volume":"9","author":"BV Babu","year":"2004","unstructured":"Babu BV, Kar SK. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa. India Trop Med Int Health. 2004;9(6):702\u20139.","journal-title":"India Trop Med Int Health"},{"issue":"11","key":"2196_CR30","doi-asserted-by":"crossref","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","volume":"7","author":"A Krentel","year":"2013","unstructured":"Krentel A, Fischer PU, Weil GJ. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2013;7(11):e2447.","journal-title":"PLoS Negl Trop Dis"},{"key":"2196_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/1755-6783.95962","volume":"5","author":"DW Njomo","year":"2012","unstructured":"Njomo DW, Amuyunzu-Nyamongo M, Mukoko DA, Magambo JK, Njenga SM. Socio-economic factors associated with compliance with mass drug administration for lymphatic filariasis elimination in Kenya: descriptive study results. Ann Trop Med Public Health. 2012;5:103\u201310.","journal-title":"Ann Trop Med Public Health"},{"issue":"2","key":"2196_CR32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4269\/ajtmh.2008.78.283","volume":"78","author":"JT Talbot","year":"2008","unstructured":"Talbot JT, Viall A, Direny A, de Rochars MB, Addiss D, Streit T, et al. Predictors of compliance in mass drug administration for the treatment and prevention of lymphatic filariasis in Leogane, Haiti. Am J Trop Med Hyg. 2008;78(2):283\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"2196_CR33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2883-6-11","volume":"6","author":"M Weerasooriya","year":"2007","unstructured":"Weerasooriya M, Yahathugoda C, Wickramasinghe D, Gunawardena K, Dharmadasa R, Vidanapathirana K, et al. Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) programme for the elimination of lymphatic filariasis in Sri Lanka. Filaria J. 2007;6(1):11.","journal-title":"Filaria J"},{"issue":"2","key":"2196_CR34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1037\/1082-989X.2.2.173","volume":"2","author":"SW Raudenbush","year":"1997","unstructured":"Raudenbush SW. Statistical analysis and optimal design for cluster randomized trials. Psychol Methods. 1997;2(2):173\u201385.","journal-title":"Psychol Methods"},{"key":"2196_CR35","volume-title":"WHO\/HTM\/NTD\/PCT\/2010.1","author":"WHO","year":"2010","unstructured":"WHO. Monitoring drug coverage for preventive chemotherapy. In: WHO, editor. WHO\/HTM\/NTD\/PCT\/2010.1. Geneva: World Health Organization; 2010."},{"key":"2196_CR36","first-page":"105","volume-title":"A supplement to the Anophelenae of Africa South of the Sahara","author":"MT Gillies","year":"1987","unstructured":"Gillies MT, Coetzee M. A supplement to the Anophelenae of Africa South of the Sahara, vol. 55. Johannesburg: South African Institute for Medical Research; 1987. p. 105\u201326."},{"key":"2196_CR37","first-page":"343","volume-title":"The Anophelinae of Africa South of the Sahara (Ethiopian Zoographical Region)","author":"MT Gillies","year":"1968","unstructured":"Gillies MT, De Meillon B. The Anophelinae of Africa South of the Sahara (Ethiopian Zoographical Region), vol. 54. Johannesburg: South African Institute for Medical Research; 1968. p. 343."},{"issue":"2","key":"2196_CR38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-3156.1997.d01-237.x","volume":"2","author":"PE Simonsen","year":"1997","unstructured":"Simonsen PE, Niemann L, Meyrowitsch DW. Wuchereria bancrofti in Tanzania: microfilarial periodicity and effect of blood sampling time on microfilarial intensities. Trop Med Int Health. 1997;2(2):153\u20138.","journal-title":"Trop Med Int Health"},{"key":"2196_CR39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s13071-014-0507-5","volume":"7","author":"PE Simonsen","year":"2014","unstructured":"Simonsen PE, Derua YA, Magesa SM, Pedersen EM, Stensgaard AS, Malecela MN, et al. Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration. Parasit Vectors. 2014;7:507.","journal-title":"Parasit Vectors"},{"key":"2196_CR40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0035-9203(97)90205-4","volume":"91","author":"RMR Ramzy","year":"1997","unstructured":"Ramzy RMR, Farid HA, Kamal IH, Ibrahim GH, Morsy ZS, Faris R, et al. A polymerase chain reaction-based assay for detection of Wuchereria bancrofti in human blood and Culex pipiens. Trans R Soc Trop Med Hyg. 1997;91:156\u201360.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"2196_CR41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parint.2011.08.018","volume":"60","author":"H Takagi","year":"2011","unstructured":"Takagi H, Itoh M, Kasai S, Yahathugoda TC, Weerasooriya MV, Kimura E. Development of loop-mediated isothermal amplification method for detecting Wuchereria bancrofti DNA in human blood and vector mosquitoes. Parasitol Int. 2011;60(4):493\u20137.","journal-title":"Parasitol Int"},{"key":"2196_CR42","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/infdis\/172.5.1414","volume":"172","author":"C Katholi","year":"1995","unstructured":"Katholi C, To\u00e9 L, Merriweather A, Unnasch T. Determining the prevalence of Onchocerca volvulus infection in vector populations by PCR screening of pools of black flies. J Infect Dis. 1995;172:1414\u20137.","journal-title":"J Infect Dis"},{"issue":"5","key":"2196_CR43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4269\/ajtmh.2006.74.779","volume":"74","author":"CR Katholi","year":"2006","unstructured":"Katholi CR, Unnasch TR. Important experimental parameters for determining infection rates in arthropod vectors using pool screening approaches. Am J Trop Med Hyg. 2006;74(5):779\u201385.","journal-title":"Am J Trop Med Hyg"},{"key":"2196_CR44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0038-1634505","volume":"37","author":"AP Plaisier","year":"1998","unstructured":"Plaisier AP, Subramanian S, Das PK, Souza W, Lapa T, Furtado AF, et al. The LYMFASIM simulation program for modeling lymphatic filariasis and its control. Methods Inf Med. 1998;37:97\u2013108.","journal-title":"Methods Inf Med"},{"key":"2196_CR45","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1017\/S0031182008000437","volume":"135","author":"WA Stolk","year":"2008","unstructured":"Stolk WA, de Vlas SJ, Borsboom GJ, Habbema JD. LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: quantification for African villages. Parasitology. 2008;135:1583\u201398.","journal-title":"Parasitology"},{"key":"2196_CR46","doi-asserted-by":"crossref","first-page":"e1984","DOI":"10.1371\/journal.pntd.0001984","volume":"7","author":"WA Stolk","year":"2013","unstructured":"Stolk WA, Ten Bosch QA, de Vlas SJ, Fischer PU, Weil GJ, Goldman AS. Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2013;7:e1984.","journal-title":"PLoS Negl Trop Dis"},{"key":"2196_CR47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1162\/qjec.121.1.73","volume":"122","author":"H Bleakley","year":"2007","unstructured":"Bleakley H. Disease and development: evidence from hookworm eradication in the American South. Q J Econ. 2007;122:73\u2013117.","journal-title":"Q J Econ"},{"key":"2196_CR48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/bmj.320.7227.114","volume":"320","author":"C Pope","year":"2000","unstructured":"Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ. 2000;320:114\u20136.","journal-title":"BMJ"},{"key":"2196_CR49","volume-title":"Cost-benefit analysis of the Onchocerciasis Control Program (OCP). Technical paper 282","author":"A Kim","year":"1995","unstructured":"Kim A, Benton B. Cost-benefit analysis of the Onchocerciasis Control Program (OCP). Technical paper 282. Washington, DC: World Bank; 1995."},{"key":"2196_CR50","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1017\/S0031182000007290","volume":"121","author":"J Horton","year":"2000","unstructured":"Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000;121:S113\u201332.","journal-title":"Parasitology"},{"key":"2196_CR51","first-page":"180","volume":"5","author":"M Offei","year":"2014","unstructured":"Offei M, Anto F. Compliance to Mass Drug Administration Programme for lymphatic filariasis elimination by community members and volunteers in the Ahanta West District of Ghana. J Bacteriol Parasitol. 2014;5:180.","journal-title":"J Bacteriol Parasitol"},{"issue":"5","key":"2196_CR52","doi-asserted-by":"crossref","first-page":"e0005619","DOI":"10.1371\/journal.pntd.0005619","volume":"11","author":"N-K Biritwum","year":"2017","unstructured":"Biritwum N-K, Garshong B, Alomatu B, de Souza DK, Gyapong M, Kyelem D. Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana. PLoS Negl Trop Dis. 2017;11(5):e0005619.","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2196-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T01:03:00Z","timestamp":1570150980000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2196-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2196"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2196-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2017,10,2]]},"article-number":"448"}}